Mediterranean diet for hidradenitis suppurativa
Part of Infections, Skin clinical trials.
This study tests whether following a Mediterranean diet (rich in fruits, vegetables, whole grains, and healthy fats) can help reduce symptoms of hidradenitis suppurativa (HS), a skin condition that causes painful lumps. You'll attend virtual visits and get support to follow the diet for 16 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- A dermatologist has confirmed your hidradenitis suppurativa diagnosis.
- You have at least 3 painful lumps or abscesses (active spots) from HS right now.
- You have not used antibiotics (by mouth, shot, or IV) in the last 28 days, and no antibiotic creams in the last 5 days.
- Your usual HS treatment has been unchanged for a month and will stay unchanged during the study.
- You can get on Zoom from your device (laptop, tablet, or phone) and complete forms in English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking capsules containing healthy gut bacteria (fecal microbiota transplant) can help treat hidradenitis suppurativa. You may qualify if you have HS and haven't taken antibiotics in the last 30 days.
This trial tests a new medicine called HB0043 for people with moderate to severe hidradenitis suppurativa (a skin condition causing painful lumps). It aims to see if the drug is safe and helps reduce symptoms.
This study looks at the physical and biological (body-related) characteristics of hidradenitis suppurativa. It may help researchers understand the condition better and improve future care.
This study tests a new medicine called LAD191 for people with moderate to severe hidradenitis suppurativa (HS) who haven't been helped enough by antibiotics. Researchers want to see if LAD191 safely reduces painful bumps and tunnels.
This study tests a new drug called LAD328 for hidradenitis suppurativa (HS), a chronic skin condition with painful lumps and abscesses. The trial is looking for adults with moderate-to-severe HS who haven't responded well to antibiotics to see if this new treatment can help reduce symptoms.
This study tests an investigational medication (olatorepatide) given as a shot (under the skin) to see if it can reduce the number of painful bumps in people with moderate-to-severe hidradenitis suppurativa who also have overweight or obesity. Participants will receive either the active drug or a placebo, and all will use standard antiseptic washes.
Hear when a new Hidradenitis Suppurativa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.